DCP

DSM Capital Partners Portfolio holdings

AUM $5.84B Turnover 50%
1-Year Est. Return 22.63%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+22.63%
3 Year Est. Return
+148.09%
5 Year Est. Return
+176.14%
10 Year Est. Return
+916.71%
AUM
$5.04B
AUM Growth
+$118M
Cap. Flow
+$27.5M
Cap. Flow %
0.55%
Top 10 Hldgs %
48.54%
Holding
87
New
11
Increased
13
Reduced
48
Closed
11
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$202M
2
BABA icon
Alibaba
BABA
+$141M
3
BIIB icon
Biogen
BIIB
+$79.7M
4
PCP
PRECISION CASTPARTS CORP
PCP
+$74.5M
5
DLTR icon
Dollar Tree
DLTR
+$62M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$145M
2
MON
Monsanto Co
MON
+$116M
3
TJX icon
TJX Companies
TJX
+$100M
4
EBAY icon
eBay
EBAY
+$79.7M
5
WBD icon
Warner Bros
WBD
+$58.1M

Sector Composition

Rank Sector Weight
1 Healthcare 32.8%
2 Consumer Discretionary 17.93%
3 Financials 12.54%
4 Communication Services 11.21%
5 Miscellaneous 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CELG
1
DELISTED
Celgene Corp
CELG
$479M 9.51%
5,057,388
-216,866
-4% -$19.6M
2013 Q2
5 quarters
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$265M 5.26%
1,598,036
+7,007
+0.4% +$1.15M
2013 Q2
5 quarters
BIIB icon
3
Biogen
BIIB
$34.3B
$255M 5.05%
769,328
+241,749
+46% +$79.7M
2013 Q4
3 quarters
BKNG icon
4
Booking.com
BKNG
$119B
$250M 4.97%
5,399,150
+30,375
+0.6% +$1.5M
2013 Q4
3 quarters
MNST icon
5
Monster Beverage
MNST
$86.4B
$226M 4.48%
29,524,704
-118,440
-0.4% -$777K
2013 Q2
5 quarters
AGN
6
DELISTED
Allergan Inc
AGN
$217M 4.31%
+1,217,422
New +$202M
2014 Q3
0 quarters
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.2T
$212M 4.21%
7,294,893
-176,283
-2% -$5.1M
2013 Q2
5 quarters
REGN icon
8
Regeneron Pharmaceuticals
REGN
$80.3B
$188M 3.72%
520,247
-11,683
-2% -$3.92M
2013 Q4
3 quarters
PCP
9
DELISTED
PRECISION CASTPARTS CORP
PCP
$179M 3.56%
757,137
+306,693
+68% +$74.5M
2013 Q2
5 quarters
SBUX icon
10
Starbucks
SBUX
$106B
$175M 3.47%
4,632,536
-209,356
-4% -$8.1M
2014 Q1
2 quarters
CTSH icon
11
Cognizant
CTSH
$28.2B
$174M 3.46%
3,889,885
-135,009
-3% -$6.35M
2013 Q3
4 quarters
BLK icon
12
Blackrock
BLK
$165B
$172M 3.41%
523,411
-18,652
-3% -$6M
2013 Q2
5 quarters
V icon
13
Visa
V
$737B
$160M 3.17%
2,997,480
-48,896
-2% -$2.63M
2013 Q2
5 quarters
MON
14
DELISTED
Monsanto Co
MON
$147M 2.93%
1,309,873
-994,695
-43% -$116M
2013 Q2
5 quarters
IVZ icon
15
Invesco
IVZ
$12.2B
$142M 2.82%
3,598,151
-48,379
-1% -$1.9M
2013 Q4
3 quarters
BABA icon
16
Alibaba
BABA
$276B
$139M 2.77%
+1,570,020
New +$141M
2014 Q3
0 quarters
YUM icon
17
Yum! Brands
YUM
$40B
$133M 2.65%
2,576,296
-503,848
-16% -$26.8M
2013 Q2
5 quarters
MA icon
18
Mastercard
MA
$529B
$131M 2.61%
1,777,869
-24,353
-1% -$1.85M
2013 Q3
4 quarters
ABT icon
19
Abbott
ABT
$177B
$128M 2.54%
3,080,501
+451,121
+17% +$19.1M
2014 Q1
2 quarters
TWX
20
DELISTED
Time Warner Inc
TWX
$120M 2.37%
1,590,014
-1,874,707
-54% -$145M
2013 Q2
5 quarters
PRGO icon
21
Perrigo
PRGO
$2.21B
$111M 2.2%
737,059
+174,207
+31% +$26M
2014 Q2
1 quarter
WYNN icon
22
Wynn Resorts
WYNN
$7.54B
$110M 2.19%
588,837
-9,834
-2% -$1.94M
2013 Q2
5 quarters
CMCSA icon
23
Comcast
CMCSA
$74.5B
$96.5M 1.91%
3,587,568
+43,100
+1% +$1.18M
2014 Q2
1 quarter
LVS icon
24
Las Vegas Sands
LVS
$23.9B
$91M 1.81%
1,462,555
-24,825
-2% -$1.71M
2013 Q2
5 quarters
DG icon
25
Dollar General
DG
$28.1B
$77.3M 1.53%
1,265,304
-19,170
-1% -$1.15M
2013 Q2
5 quarters

Similar funds

DSM Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, DSM Capital Partners held 87 positions worth $5.04B, up 2.4% from $4.92B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

DSM Capital Partners's Q3 2014 filing shows 11 new, 13 increased, 48 reduced and 11 closed positions. Its largest new stake was Allergan Inc: 1,217,422 shares worth $217M. The largest sale was Time Warner Inc, an estimated $145M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • DSM Capital Partners's largest Q3 2014 buy was Allergan Inc: 1,217,422 shares worth $217M.
  • DSM Capital Partners added most to Biogen in Q3 2014, an estimated $79.7M increase.
  • DSM Capital Partners's biggest Q3 2014 reduction was Time Warner Inc, cutting an estimated $145M.
  • DSM Capital Partners fully exited TJX Companies in Q3 2014, selling an estimated $100M.
  • DSM Capital Partners's ten largest holdings make up 49% of its $5.04B portfolio in Q3 2014.
  • DSM Capital Partners opened 11 new positions and closed 11 in Q3 2014.
  • DSM Capital Partners's portfolio value rose 2.4% quarter-over-quarter to $5.04B.

Based on DSM Capital Partners's 13F filing for Q3 2014, filed 13 Nov 2014.